Mannich-Type Reactions
FULL PAPER
layers were dried over anhydrous Na2SO4. Finally, the solvents were
evaporated, and the residue was purified by preparative TLC (silica gel,
CHCl3/MeOH 39:1) to give (R)-4 (93% yield). The enantiomeric excess
of the product was determined by HPLC analysis (92% ee).
7.78; N 8.44; HPLC (Daicel Chiralcel OD, hexane/iPrOH 19:1, flow
rate=1.0 mLminÀ1); syn: tR =14.2min (major), tR =17.2min (minor);
anti: tR =22.2 min (major), tR =27.0 min (minor).
A typical experimental procedure for the Mannich-type reactions with
acetophenone-derived silyl enol ether 3 in water (Table 12, entry 1):
Compound 2 (0.421 mmol) and 3 (1.26 mmol) were added to a mixture
of 1i (0.0421 mmol) and ZnF2 (0.421 mmol) in H2O (2.35 mL), and the
mixture was stirred vigorously (~1400 rpm) at 08C. After 20 h, the reac-
tion was quenched with saturated aqueous NaHCO3. The resultant mix-
ture was then extracted with dichloromethane (3), and the combined
organic layers were dried over anhydrous Na2SO4. Finally, the solvent
was evaporated, and the residue was purified by preparative TLC (silica
gel, chloroform/MeOH 39:1 and then hexane/ethyl acetate 3:2) to give
Mannich adduct (R)-4 (91% yield, 95% ee).
Ethyl 2-(N’-benzoylhydrazino)-4-oxo-4-phenylbutyrate (4a):[7] [a]D22
=
+4.42( c=5.07 in CHCl3, 96% ee); 1H NMR (CDCl3): d=1.23 (t, J=
7.1 Hz, 3H), 3.51 (dd, J=17.9, 6.5 Hz, 1H), 3.60 (dd, J=17.9, 4.9 Hz,
1H), 4.06–4.35 (m, 3H), 5.51 (brs, 1H), 7.31–7.64 (m, 6H), 7.74 (d, J=
7.6 Hz, 2H), 7.93 (d, J=7.6 Hz, 2H), 8.50 ppm (brd, J=4.4 Hz, 1H);
13C NMR (CDCl3): d=14.0, 39.4, 59.0, 61.4, 126.9, 128.0, 128.5, 128.5,
131.7, 132.6, 133.4, 136.1, 166.9, 172.5, 197.1 ppm; IR (neat): n˜ =3289,
1735, 1681, 1536, 1216, 689 cmÀ1; MS: m/z: 340 [M]+; HRMS: calcd for
C19H20N2O4: 340.1423; found: 340.1379; HPLC (Daicel Chiralcel OD,
hexane/iPrOH 4:1, flow rate=1.0 mLminÀ1): tR =11.9 min (R), tR =
17.7 min (S).
A typical experimental procedure for the Mannich-type reactions of pro-
piophenone-derived silyl enol ether 5 in water (Table 13, entry 5): A solu-
tion of CTAB (0.0716m, 0.0200 mmol) in H2O, 2 (0.400 mmol), and 5
(1.20 mmol) were added to a mixture of ZnF2 (0.400 mmol) and 1c
(0.0400 mmol) in H2O (1.95 mL), and the mixture was stirred vigorously
(~1400 rpm) at 08C. After 20 h, the reaction was quenched with saturat-
ed aqueous NaHCO3. The resultant mixture was then extracted with di-
chloromethane (3), and the combined organic layers were dried over
anhydrous Na2SO4. Finally, the solvent was evaporated, and the residue
was purified by preparative TLC (silica gel, hexane/ethyl acetate 2:1, 2)
to give Mannich adduct 6 (94% yield, syn/anti 94:6, 97% ee (syn)).
Ethyl 2-(N’-benzoylhydrazino)-4-oxo-4-p-tolylbutyrate (4b):[7] 1H NMR
(CDCl3): d=1.25 (t, J=7.1 Hz, 3H), 2.40 (s, 3H), 3.51 (dd, J=17.8,
6.3 Hz, 1H), 3.59 (dd, J=17.8, 4.6 Hz, 1H), 4.06–4.37 (m, 3H), 5.40–5.52
(brs, 1H), 7.16–7.56 (m, 5H), 7.73 (d, J=7.3 Hz, 2H), 7.84 (d, J=8.3 Hz,
2H), 8.27 ppm (brd, J=5.1 Hz, 1H); 13C NMR (CDCl3): d=14.1, 21.6,
39.4, 59.2, 61.5, 126.9, 128.2, 128.6, 129.3, 131.8, 132.7, 133.7, 144.4, 166.8,
172.7, 196.8 ppm; IR (neat): n˜ =3295, 2924, 1735, 1680, 1606, 1181 cmÀ1
;
HRMS: calcd for C20H22N2O4: 354.1580; found: 354.1548; HPLC (Daicel
Chiralcel OD, hexane/iPrOH 4:1, flow rate=1.0 mLminÀ1): tR =12.0 min
(R), tR =17.0 min (S).
Ethyl
2-(N’-benzoylhydrazino)-4-(4-methoxyphenyl)-4-oxobutyrate
Ethyl 2-(N’-benzoylhydrazino)-4-tert-butylthio-3-methyl-4-oxobutanoate
(6c):[8] 1H NMR (CDCl3); syn: d=1.28 (t, J=7.2Hz, 3H), 1.31 (d, J=
7.1 Hz, 3H), 1.44 (s, 9H), 3.12(dq, J=4.3, 7.1 Hz, 1H), 4.00 (dd, J=3.7,
4.3 Hz, 1H), 4.15–4.29 (m, 2H), 5.50 (dd, J=3.7, 6.3 Hz, 1H), 7.38–7.44
(m, 2H), 7.46–7.52 (m, 1H), 7.71–7.77 (m, 2H), 8.08 ppm (brd, J=
6.3 Hz, 1H); 13C NMR (CDCl3); syn: d=13.2, 14.0, 29.6, 48.3, 49.5, 61.4,
64.5, 126.9, 128.5, 131.7, 132.5, 166.7, 171.1, 201.8 ppm; 1H NMR
(CDCl3); anti: d=1.27 (t, J=7.1 Hz, 3H), 1.29 (d, J=7.1 Hz, 3H), 1.47
(s, 9H), 3.10 (dq, J=6.8, 7.1 Hz, 1H), 3.85 (dd, J=6.2, 6.8 Hz, 1H), 4.09–
4.35 (m, 2H), 5.32 (dd, J=5.4, 6.2Hz, 1H), 7.39–7.56 (m, 3H), 7.70–7.79
(m, 2H), 7.94 ppm (brd, J=5.4 Hz, 1H); 13C NMR (CDCl3); anti: d=
14.1, 14.5, 29.7, 48.4, 49.4, 61.4, 65.9, 126.9, 128.6, 131.8, 132.6, 166.9,
171.4, 201.4 ppm; IR (neat, syn/anti 8:92): n˜ =3292, 2966, 1738, 1680,
(4c):[7] 1H NMR (CDCl3): d=1.25 (t, J=7.2Hz, 3H), 3.49 (dd, J=17.6,
6.3 Hz, 1H), 3.57 (dd, J=17.6, 4.4 Hz, 1H), 3.87 (s, 3H), 4.10–4.33 (m,
3H), 5.29–5.60 (m, 1H), 6.92 (d, J=8.8 Hz, 2H), 7.36–7.46 (m, 2H), 7.50
(t, J=7.3 Hz, 1H), 7.73 (d, J=7.3 Hz, 2H), 7.93 (d, J=8.8 Hz, 2H),
8.26 ppm (brs, 1H); 13C NMR (CDCl3): d=14.1, 39.2, 55.5, 59.2, 61.5,
113.8, 126.9, 128.6, 129.3, 130.5, 131.8, 132.7, 163.8, 166.8, 172.8,
195.7 ppm; IR (neat): n˜ =3257, 1740, 1686, 1627, 1600, 1453, 1262, 1222,
1192, 1169 cmÀ1; MS: m/z: 370 [M]+; HPLC (Daicel Chiralcel OD,
hexane/iPrOH 4:1, flow rate=1.0 mLminÀ1): tR =19.6 min (R), tR =
28.2 min (S).
Ethyl 2-(N’-benzoylhydrazino)-4-(4-chlorophenyl)-4-oxobutyrate (4d):[7]
1H NMR (CDCl3): d=1.22 (t, J=7.1 Hz, 3H), 3.46 (dd, J=17.9, 6.2Hz,
1H), 3.56 (dd, J=17.9, 5.0 Hz, 1H), 4.10–4.34 (m, 3H), 5.52(brs, 1H),
7.32–7.55 (m, 5H), 7.69–7.79 (m, 2H), 7.85 (d, J=8.6 Hz, 2H), 8.55 ppm
(brd, J=5.0 Hz, 1H); 13C NMR (CDCl3): d=14.1, 39.4, 59.1, 61.6, 127.0,
128.6, 129.0, 129.5, 131.9, 132.5, 134.5, 140.0, 167.0, 172.3, 196.0 ppm; IR
(neat): n˜ =3293, 1733, 1683, 1590, 1535, 1215, 693 cmÀ1; MS: m/z: 374
[M]+; HPLC (Daicel Chiralcel OD, hexane/iPrOH 4:1, flow rate=
1.0 mLminÀ1): tR =14.0 min (R), tR =19.7 min (S).
Ethyl 2-(N’-benzoylhydrazino)-3-methyl-4-oxo-4-phenylbutyrate (6a):[7]
M.p. 120–1228C; [a]2D3 =+24.5 (c=0.40 in CHCl3, syn/anti 99.7:0.3,
>99.5% ee (syn)); 1H NMR (CDCl3); syn: d=1.23 (t, J=7.1 Hz, 3H),
1.28 (d, J=7.1 Hz, 3H), 3.88–4.37 (m, 4H), 4.83 (brs), 7.30–7.61 (m, 6H),
7.71 (d, J=7.3 Hz, 2H), 7.94 (d, J=7.1 Hz, 2H), 8.29 ppm (brs, 1H); de-
tectable peak of anti isomer: 8.14 ppm (brs, 1H); 13C NMR (CDCl3);
syn: d=13.9, 14.2, 42.5, 61.2, 65.9, 126.9, 128.3, 128.4, 128.6, 131.6, 132.5,
133.1, 136.0, 166.8, 172.1, 201.5 ppm; IR (KBr): n˜ =3269, 1732, 1682,
1628, 1551, 1194, 706 cmÀ1; MS: m/z: 354 [M]+; elemental analysis calcd
for C20H22N2O4: C 67.78, H 6.26, N 7.90; found: C 67.84, H 6.47, N 7.93;
HPLC (Daicel Chiralcel OD, hexane/iPrOH 19:1, flow rate=
1.0 mLminÀ1); syn: tR =23.5 min (major), tR =28.2 min (minor); anti: tR =
31.4 min (major), tR =32.9 min (minor).
1456, 1211, 964, 696 cmÀ1
; HRMS (FAB): calcd for C18H27N2O4S:
367.1692[ M+H]+; found: 367.1671; HPLC (Daicel Chiralpak AD-H
(double), hexane/iPrOH 4:1, flow rate=0.50 mLminÀ1); syn: tR =
34.8 min (2S,3S), tR =41.4 min (2R,3R). anti: tR =28.8 min (2S,3R), tR =
33.1 min (2R,3S).
Ethyl 2-(N’-benzoylhydrazino)-3-methyl-4-oxohexanoate (6d):[8] syn (syn/
anti 98.5:1.5, >99.5% ee (syn)): m.p. 117–1198C; [a]2D5 =+8.3 (c=0.25 in
CHCl3); 1H NMR (CDCl3): d=1.06 (t, J=7.2Hz, 3H), 1.23 (d, J=
7.2Hz, 3H), 1.26 (t, J=7.2 Hz, 3H), 2.43–2.66 (m, 2H), 3.08 (dq, J=7.2,
7.2Hz, 1H), 3.87 (d, J=7.2Hz, 1H), 4.12–4.30 (m, 2H), 4.84 (brs, 1H),
7.37–7.56 (m, 3H), 7.70–7.79 (m, 2H), 8.08 ppm (s, 1H); 13C NMR
(CDCl3): d=7.6, 13.5, 14.1, 34.7, 47.1, 61.3, 65.5, 126.9, 128.6, 131.8,
132.6, 166.7, 172.0, 212.2 ppm; IR (KBr): n˜ =3251, 1730, 1711, 1626, 1556,
1452, 1205, 694 cmÀ1
; HRMS (ESI-TOF): calcd for C16H22N2O4Na:
329.1477 [M+Na]+; found: 329.1460; anti: 1H NMR (CDCl3): d=1.04 (t,
J=7.2Hz, 3H), 1.25 (d, J=7.2Hz, 3H), 1.26 (t, J=7.2Hz, 3H), 2.48–
2.70 (m, 2H), 3.11 (dq, J=4.9, 7.2Hz, 1H), 3.98 (dd, J=4.5, 4.9 Hz, 1H),
4.10–4.29 (m, 2H), 5.35 (dd, J=4.5, 5.5 Hz, 1H), 7.36–7.54 (m, 3H),
7.70–7.78 (m, 2H), 8.18 ppm (brd, J=5.5 Hz, 1H); 13C NMR (CDCl3):
d=7.5, 12.4, 14.0, 34.3, 46.9, 61.3, 64.0, 126.8, 128.5, 131.7, 132.4, 166.9,
171.7, 212.3 ppm; HPLC (Daicel Chiralpak AD-H, hexane/iPrOH 9:1,
flow rate=0.80 mLminÀ1); syn: tR =23.9 min (minor), tR =33.7 min
(major); anti: tR =26.7 min (minor), tR =44.3 min (major).
Ethyl
2-(N’-benzoylhydrazino)-3,5-dimethyl-4-oxohexanoate
(6b):[7]
1H NMR (CDCl3); syn: d=1.11 (d, J=6.8 Hz, 3H), 1.12(d, J=6.8 Hz,
3H), 1.23 (d, J=7.2Hz, 3H), 1.26 (t, J=7.1 Hz, 3H), 2.73–2.91 (m, 1H),
3.24 (quin, J=7.2Hz, 1H), 3.81 (d, J=7.2Hz, 1H), 4.21 (dq, J=7.1,
3.2Hz, 1H), 7.38–7.56 (m, 3H), 7.69–7.78 (m, 2H), 8.08 ppm (brs, 1H);
detectable peak of the anti isomer: 3.93 ppm (d, J=4.8 Hz, 1H);
13C NMR (CDCl3); syn: d=13.7, 14.1, 18.1, 18.3, 39.6, 45.7, 61.4, 65.8,
126.9, 128.6, 131.8, 132.6, 166.7, 172.4, 215.7 ppm; IR (KBr): n˜ =3253,
3228, 1731, 1707, 1625, 1204, 696 cmÀ1; MS: m/z: 32 0 M[ ]+; elemental
analysis calcd for C17H24N2O4: C 63.73, H 7.55, N 8.74; found: C 63.70, H
Ethyl 2-(N’-benzoylhydrazino)-3-methyl-4-(4-methoxyphenyl)-4-oxobuty-
rate (6e): syn: m.p. 117–1188C; [a]2D5 =+12.5 (c=0.51 in CHCl3);
1H NMR (C6D6): d=0.97 (t, J=7.1 Hz, 3H), 1.27 (d, J=6.9 Hz, 3H),
3.20 (s, 3H), 3.92–4.12 (m, 3H), 4.42 (dd, J=7.6, 7.6 Hz, 1H), 5.90 (dd,
J=7.6, 6.0 Hz, 1H), 6.65 (d, J=8.7 Hz, 2H), 6.95–7.10 (m, 3H), 7.69 (d,
J=8.2Hz, 2H), 7.97 (d, J=8.7 Hz, 2H), 8.36 ppm (d, J=6.0 Hz, 1H);
13C NMR (CDCl3): d=14.1, 14.8, 42.1, 55.5, 61.3, 66.2, 113.9, 126.9, 128.5,
Chem. Eur. J. 2006, 12, 1205 – 1215
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1213